Eltoukhy Helmy's Form 4 filing
Guardant Health, Inc. (GH) · filed Mar 16, 2023
- Accession no.
- 0001576280-23-000040
- Filed
- Mar 16, 2023
- Trade date
- Mar 14-15, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $2.45M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eltoukhy HelmyCIK 0001752968 | Director, Officer (Co-Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average price of shares purchased at prices that ranged from $26.245 to $26.50.
Referenced by the price of 1 transaction in Table I.
- F2
Represents the weighted average price of shares purchased at prices that ranged from $26.13 to $26.27.
Referenced by the price of 1 transaction in Table I.